Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Firefly Neuroscience (AIFF) Research & Development (2023 - 2025)

Firefly Neuroscience has reported Research & Development over the past 3 years, most recently at $456000.0 for Q4 2025.

  • Quarterly results put Research & Development at $456000.0 for Q4 2025, up 4.35% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (down 24.16% YoY), and the annual figure for FY2025 was $1.5 million, down 24.16%.
  • Research & Development for Q4 2025 was $456000.0 at Firefly Neuroscience, up from $378000.0 in the prior quarter.
  • Over the last five years, Research & Development for AIFF hit a ceiling of $878000.0 in Q3 2024 and a floor of $29000.0 in Q4 2023.
  • Median Research & Development over the past 3 years was $364000.0 (2024), compared with a mean of $385700.0.
  • Biggest five-year swings in Research & Development: surged 1406.9% in 2024 and later crashed 56.95% in 2025.
  • Firefly Neuroscience's Research & Development stood at $29000.0 in 2023, then surged by 1406.9% to $437000.0 in 2024, then increased by 4.35% to $456000.0 in 2025.
  • The last three reported values for Research & Development were $456000.0 (Q4 2025), $378000.0 (Q3 2025), and $336000.0 (Q2 2025) per Business Quant data.